Guest lecture on Building digital health for chronic diseases across Europe with Oviva: Kai Eberhardt, 24 March 2023
Friday, 24 March, 10:00-11:30AM CET
About Kai Eberhardt
Kai Eberhardt is CEO and co-founder of Oviva, a digital health company focusing on treating diet-related, chronic diseases.
He worked on healthcare topics from the age of 20, starting from when he was treated for cancer. He has a PhD in physics, studying at ETH Zurich and Havard Medical School, advancing medical imaging technology.
Before Oviva, Kai was a junior partner with McKinsey, helping pharmaceutical and medical device manufacturers with market access and sales.
About the Lecture
The presentation is a perspective on how Oviva scaled to one of the most successful digital health startups in Europe. Over 9 years, the startup grew from 0 to 400’000 patients and 700 employees across Germany, the UK, France, and Switzerland, raising over $120m in funding from top-tier VCs. We will cover a wide range of topics, e.g., product, clinical, reimbursement, sales and funding, and most of all how to bring that together to a functioning whole.
We are pleased to invite you to join this guest lecture. Registration is not required. Please be aware that we will be recording this guest lecture and will be making it available in our teaching library. If you have any questions, please contact Ivana Cabalzar (firstname.lastname@example.org) prior to the start of the guest lecture.
Prof. Dr. Tobias Kowatsch, Associate Professor for Digital Health Interventions, Institute for Implementation Science in Health Care, University of Zurich; Director, School of Medicine, University of St.Gallen (HSG); Scientific Director, Centre for Digital Health Interventions (CDHI), ETH Zurich & HSG; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore
Prof. Dr. Elgar Fleisch, Professor of Information Management, ETH Zürich; Professor of Technology Management, University of St.Gallen; Advisory Board Member, CDHI, ETH Zürich & University of St.Gallen; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore
Prof. Dr. Florian von Wangenheim, Professor of Technology Marketing, ETH Zurich & Advisory Board Member, CDHI; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore